The Administration for Children's Services (ACS) is partnering with NYU College of Dentistry to provide dental screenings to children in foster care onsite at the Nicholas Scoppetta Children’s Center via a mobile dental care program.

As part of this partnership, NYU College of Dentistry will offer weekly, 30-minute educational sessions on oral health at the Children’s Center, followed by screenings and restorative treatment (fillings). Children requiring additional treatment will be referred to and seen on expedited appointments at NYU College of Dentistry. As the partnership progresses, the goal is to provide similar dental services for the rest of ACS' programs through NYU where appropriate.

"Today's ACS is committed to enhancing the lives of the children we serve, and this new partnership, with NYU College of Dentistry, is one more way that we're providing the most comprehensive care possible to children in New York City," said ACS Commissioner David Hansell. "What this partnership means is that thousands of kids in foster care will have easier access to critical dental services — like screenings, fillings, and more — which will put them on track to a healthier life overall. I want to thank NYU College of Dentistry for its partnership and leadership."

"Studies conducted at the NYU College of Dentistry have demonstrated that when children lose the family structure that is needed to help manage their diet, brushing, and routine dental care, it affects their oral health, including an increase in tooth decay," said Mark S. Wolff, DDS, PhD, Professor and Chair of the Department of Cariology and Comprehensive Care at NYU College of Dentistry. "NYU Dentistry is committed through this program to begin the process of improving oral health for this most vulnerable group of children."

Each year, 51 million school hours are lost nationally due to dental-related illness. According to the American Academy of Pediatrics, nearly 40 percent of children in foster care have significant oral issues. In addition to pain and infection, issues with oral health can mean difficulty eating or speaking.

According to NYU College of Dentistry, the single most common chronic childhood disease is dental caries (cavities); it occurs five times more often than asthma and seven times more often than hay fever. Children in poverty experience twice the caries rate as those who are not poor. They are four times more likely to be untreated for these issues.

All children in foster care receive medical and dental screenings when they first enter foster care as well as ongoing dental and medical care. Having this dental clinic on-site at the Children's Center will now mean faster, easier access to dental care.

The Nicholas Scoppetta Children's Center is a child-friendly facility that operates 24 hours a day, temporarily housing children and youth who are not placed immediately after removal from their homes. An interdisciplinary team of Child Protective Specialists, Social Workers, Nurses, Psychologists, Psychiatrists, Child Care, and Administrative staff provide support and clinical services to children to reduce trauma associated with child maltreatment, as well as loss and separation from their parents and primary caregivers. This is a unique safe haven, reception, assessment, and temporary transition center for children entering the foster care system. All daily living needs are provided to protect vulnerable children in a safe and child-friendly environment on a 24/7 basis. This includes stabilizing fragile children while caring for their medical, social, emotional, and physical needs, and concurrently providing children with a smooth transition to placement.

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that it has entered the rapidly growing market for orthodontic aligners with its proprietary SLX™ Clear Aligner System.

The SLX™ Clear Aligner System is a complete solution that incorporates the popular Sagittal First/Motion 3D technology, a proprietary offering of the Company's Henry Schein Orthodontics (HSO) business. According to HSO's lead clinical advisor, Dr. Dave Paquette, Sagittal First/Motion 3D can significantly reduce the number of aligners needed for use in a typical case, providing meaningful time savings and clinical benefits to doctors and patients alike.

This new and innovative system offers clinicians and patients an intuitive and simplified treatment process, and was introduced today by Henry Schein Orthodontics at the annual session of the American Association of Orthodontists, in Washington, D.C.

The SLX™ Clear Aligner System, which has been cleared by the U.S. Food and Drug Administration, uses patented manufacturing processes to achieve aligner clarity and a precise fit for greater comfort and improved tooth control. The SLX™ Clear Aligner web portal will accept STL digital impressions from all leading intraoral scanners and, combined with an open-source platform, is easy to use.

"Henry Schein is committed to providing clinicians with the most advanced and patient-friendly treatment options available," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "With the launch of SLX™ Clear Aligners, based on the Sagittal First/Motion 3D technology, we are advancing that mission while positioning the Company globally as a full-solution provider of innovative orthodontic products. We see considerable growth opportunities in this market, and we are pleased to provide clinicians a new way of satisfying the oral health needs of their patients."

The SLX™ Clear Aligner System provides an enhanced aesthetic orthodontic treatment option for consumers, as well as an easy-to-use case submission and treatment planning process for clinicians that offers high-quality outcomes. SLX™ Clear Aligners join HSO's growing family of innovative SLX™ Orthodontic solutions.

"HSO is excited to be entering the large and growing market for clear aligners," said Ted Dreifuss, General Manager of Henry Schein Orthodontics. "Clear aligners are gaining wider acceptance among patients and orthodontic providers alike. We have designed our aligner solution to provide a new choice for patients who are looking for either a simple aesthetic solution to problems such as minor crowding or for those requiring more extensive work to correct issues such as bite problems and moderate or severe crowding. With our easy-to-use intuitive interface, we believe orthodontists will spend less time submitting and approving their cases, further enhancing Henry Schein's mission to help clinicians focus on providing quality care."

With today's launch, Henry Schein Orthodontics will begin registration and training immediately. Case submission will begin on May 25.

About Henry Schein Orthodontics

Henry Schein Orthodontics provides a wide range of orthodontic products to the worldwide dental market. The Company sells directly to U.S. practitioners and through an established network of independent dealers in International markets. For more information on Henry Schein Orthodontics contact us at: 800.547.2000 or 760.448.8600, via email: usasales@henryscheinortho.com or via our Web site at www.HenryScheinOrtho.com

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members serving more than 1 million customers globally, the Company is the world's largest provider of Business, Clinical, and Technology solutions to enhance the efficiency of office-based dental, animal health, and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.

A Fortune 500® Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein's network of trusted advisors provides health care professionals with the valued solutions they need to improve operational success and clinical outcomes. The Company offers customers exclusive, innovative products and solutions, including practice management software, e-commerce solutions, specialty and surgical products, as well as a broad range of financial services. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.  

Anutra Medical, a medical device company, has donated anesthetic supplies to support the South Sound Free Dental Day. This annual event is in its third year and is presented by Light Dental Studios, a multi-site dental care organization in the South Puget Sound, Washington area. Thirty-five doctors and over two hundred staff members from Light Dental will be donating their time to help provide select dental services to those in their community at no charge.

Prospective patients can visit Light Dental Studios’ Puyallup, University Place or Olympia locations between 8:00 AM PST and 1:00 PM PST on Saturday, May 5, 2018 to be assessed for care and may choose between a free filling or extraction.

The Anutra Local Anesthetic Delivery System, by Anutra Medical, has been the choice anesthetic delivery method for Light Dental Studios. The system leverages the science of buffering to reduce the high levels of acid found in local anesthetic. The result of buffering anesthetic provides a more comfortable experience for the patient. Many patients have been quoted saying that the injection was “painless” or that they “didn’t feel a thing” when they received an injection.

Not only is buffering beneficial to the patient’s comfort, it is also a more predictable way of administering local anesthetic for the provider. Buffered anesthetic is more reliable and has a higher likelihood of getting patients numb very quickly, each and every time. Traditional methods of anesthetic administration results in inconsistent results where some patients are unable to fully become numb or it is a time consuming process requiring multiple injections.

“Donating anesthetic to events like South Sound Free Dental Day allows all patients to receive a comfortable injection. Further, due to the speed of the anesthetic and the reliability, the doctors will be able to provide more care to more patients without running the risk of failed or slow-acting anesthetic,” says Jeff Daner, President and Head of Sales at Anutra Medical.

For more information on South Sound Free Dental Day, patients can visit the Light Dental Studios’ website at www.lightdentalstudios.com.

SciCan, Inc. is proud to announce the promotion of Steve Marble to Eastern Regional Sales Manager. Steve will have sales management responsibilities for eight SciCan Sales Representatives from New England to Florida.

Steve has over twelve years of experience in the dental industry and has spent ten of those years with SciCan. He has had tremendous success as a Sales Representative in the New England area and has also served as SciCan’s US Sales Trainer for the past five years, a job he will continue in along with his new role.

Rich Strader, SciCan President states “He is an expert in Infection Control and has a passion to help others succeed and grow professionally. Steve is a great asset to our company and to the reps and accounts in his new region.”

SciCan, Inc., manufacturer of infection control products, is proud to announce Scott Rinnas as its new Sales Representative based in Chicago, IL.

Scott will be responsible for managing SciCan’s product lines in Northern Illinois, Wisconsin, and Northern Michigan.

Scott comes to us with an extensive background in the US dental market. He has held positions across the country with Henry Schein Dental, and most recently Crosstex International. Scott holds a Bachelors degree from Michigan State University in Marketing, Sales, and Entrepreneurship.

SciCan, Inc. is proud to welcome Travis Wannemuehler to the newly created position of Sales Representative, Infection Control in Baltimore, MD. Travis’ responsibilities include working closely with our distributors and our local SciCan Sales Reps to sell the OPTIM product line to dental offices.

SciCan, Inc. is proud to welcome Sheila Barone to the newly created position of Sales Representative, Infection Control in Denver, CO. Sheila’s responsibilities include working closely with our distributors and our local SciCan Sales Reps to sell the OPTIM product line to dental offices.

SciCan, Inc. is proud to welcome Kendrick White to the newly created position of Sales Representative, Infection Control in Kansas City, MO. Kendrick’s responsibilities include working closely with our distributors and our local SciCan Sales Reps to sell the OPTIM product line to dental offices.

SciCan, Inc. is proud to welcome John Mudd to the newly created position of Sales Representative, Infection Control in Los Angeles, CA. John’s responsibilities include working closely with our distributors and our local SciCan Sales Reps to sell the OPTIM product line to dental offices.

SciCan, Inc. is proud to welcome Erica Smith to the newly created position of Sales Representative, Infection Control in Atlanta, GA. Erica’s responsibilities include working closely with our distributors and our local SciCan Sales Reps to sell the OPTIM product line to dental offices.

SciCan, Inc., manufacturer of infection control products, is proud to announce Mark Pontarelli as its new Sales Representative based in Nashville, TN.

Mark will be responsible for managing SciCan’s product lines in Alabama, Mississippi, Kentucky and parts Tennessee and Florida.

Mark has an extensive background in the US dental market. He was in equipment and clinical sales for a-dec for twelve years in the Southeast, as well as Arizona. Mark also marketed an all-tissues laser for one year with Convergent Dental.

SciCan, Inc. is proud to welcome John Mudd to the newly created position of Sales Representative, Infection Control in Los Angeles, CA. John’s responsibilities include working closely with our distributors and our local SciCan Sales Reps to sell the OPTIM product line to dental offices.

SciCan is proud to announce SALUS, the world’s first paperless rack & sleeve dental Instrument Reprocessing Container.

The revolutionary SALUS - Hygiene instrument reprocessing container eliminates the costly and time consuming use of sterilization paper and pouches. It is a safe, convenient, and simple alternative to the traditional hassles of sterilizing, organizing, and storing dental hygiene instruments. SALUS is designed to work in tandem with autoclave monitoring systems and is suitable for use within ultrasonic and automatic washers, thermal-disinfectors and steam sterilizers.

SAFE: SALUS’ temperature-activated security lock system ensures the container has been processed through a steam sterilizer. The unit’s hard shell further protects both instruments and user, eliminating the risk of contamination due to punctured wrap or injury from loose instruments.

CONVENIENT: SALUS has been verified to maintain sterility for up to 30 days. SALUS is the safe, convenient, simple way of sterilizing and managing instruments that benefits the patient, the practitioner and the bottom line.

SIMPLE: With SALUS, dental professionals are no longer required to process instruments in pouches or use sterilization wrap. This enhances office productivity while minimizing the potential for injury and human error.

About SciCan, Inc.

Through a sustained legacy of product innovation and refinement, SciCan has set the benchmark for sterilization and instrument reprocessing technology in over 100 countries around the world. Originally founded in 1957, SciCan develops and manufactures highly innovative infection control products that address the need for speed, flexibility, and efficiency in today’s environments.

In 1989, SciCan developed and produced an internationally recognized infection control innovation, the STATIM® Cassette Autoclave. Over the next quarter century, SciCan continued to be at the forefront of technology with the release of the HYDRIM® Instrument Washers, BRAVO Chambered Autoclaves, and G4 Networking Technology. SciCan’s HYDRIM®, STATIM®, and BRAVO™ are designed to be the fastest and most efficient instrument washers and autoclaves on the market.

Pacific Dental Services (PDS®), one of the country’s leading dental support organizations (DSO), honored clinical leaders and employees at the company’s eXtraordinary Performance (XP) event in Las Vegas. The three-day event kicked off on April 25 at the Bellagio Resort, with more than 2,300 PDS team members and guests in attendance.

The conference featured powerful keynotes from “Good Morning America’s” Robin Roberts and Armando Perez, aka Pitbull. Roberts addressed a standing-room-only crowd on the power of leadership and positivity, underscoring the “Healthier and Happier” conference theme. Like Roberts, Pitbull emphasized the importance of turning negatives into positives and the hard work required to achieve success, before surprising guests with a live concert. PDS recognized top performers from across the organization for their contributions to the company’s continued success and underscored how their commitment to clinical excellence has helped patients and communities become healthier and happier.

“This year marks our best XP yet,” said Stephen Thorne IV, PDS CEO and Founder. “We’ve brought together team members from across the organization to articulate their personal vision for leadership so they can help their team members provide the Perfect Patient Experience®.”

Throughout the event, Thorne emphasized the importance of both caring for and serving other people while investing in personal and professional development to reach your potential. He also outlined how the dental industry will evolve and how each PDS team member contributes to achieving the company’s vision to be the Greatest Dental Company in America.

PDS reinforced the company’s model of Clinicians Leading Clinicians in Clinical Excellence® throughout the event as new dentists collaborated with more experienced practice owners to find their personal vision for success Attendees participated in over 80 breakout sessions focused on both “Healthier” and “Happier,” including such topics as enhancing patient care, the clinical experience, trustworthy relationship-building, public speaking, and financial planning.

About Pacific Dental Services®

Founded in 1994, Pacific Dental Services (PDS) is one of the country’s leading dental support organizations, providing supported autonomy that enables dentists to concentrate on clinical excellence and the highest levels of cost-effective comprehensive patient care. PDS originated the Private Practice+® model to enable dentists to focus on their passion: serving patients. PDS also pioneered the concept of Modern Dentistry so that dentists are equipped to combine advances in the latest technology with the best operational practices and procedures, highly skilled support staff and a commitment to ongoing training and education. PDS continues to grow, with over 635 supported dental offices across the United States and plans to expand into several new markets. PDS has been on the Inc. 5000 list of the

2 fastest growing private companies in America for the past 10 years in a row. PDS aims to be the provider of choice in all the markets they serve, helping supported dentists to develop Patients for Life™.

Dr. Dipesh Parmer is making an impact in the world of dentistry. He has been presenting sold out lectures at some of the major dental meetings in the US and Europe. His incredible eye for composite artistry has won him numerous prizes in the UK in Restorative, Prosthetic, Conservative and Aesthetic Dentistry. On September 14-15, Dr. Parmer is presenting “Excellence in Direct Anterior Restorations” at the Center for Esthetic Excellence in Chicago. Call now to reserve your spot at 800-837-2321 or visit us online at www.CeeChicago.com.

Therese (Tree) Mainella has been named VP of Clinical Affairs for Parkell, Inc., a subsidiary of Directa Dental Group (Sweden). Mainella’s duties will include managing the company’s Key Opinion Leaders in addition to providing education to various dental and hygiene schools on implementation of Parkell products. The company’s new training center located at corporate headquarters (Edgewood, NY), will be under the directive of Mainella. Parkell will host a series of continuing education courses featuring nationally and locally renowned keynote speakers. The center is scheduled to open in June, 2018.

Convergent Dental, Inc., developers of Solea®, the industry-leading CO2 all-tissue dental laser system, is pleased to announce two new appointments to its executive leadership team. Daryl Donatelli recently joined the Company as Vice President of Marketing, and Charles Kerbage now holds the title of Vice President of Research and Development.

In his new role as Vice President of Marketing, Daryl Donatelli will drive all marketing efforts for Convergent Dental’s flagship product Solea, the #1 selling dental laser for hard, soft, and osseous tissue procedures. Donatelli will lead Convergent Dental’s marketing team efforts including product strategy, marketing communications, business partnerships, and sales enablement.

“I’m very excited to be part of creating what will definitely be a new standard of care for dentistry,” remarked Donatelli. “I am even more excited about enabling an experience for patients that will forever change what it means to go to the dentist.”

Donatelli brings over fifteen years of executive marketing experience to Convergent Dental, including the commercialization and growth of major medical devices and consumer health portfolios across North America, Asia, and Europe.

Donatelli holds a BA in Economics from the University of Rochester, and an MBA from Simon Business School.

Charles Kerbage has joined Convergent Dental as Vice President of Research and Development. Kerbage will lead the Company’s R&D team in identifying opportunities for innovation that will both improve existing product performance and bring new capabilities into the company’s product portfolio.

“Having come from the laser industry, I was attracted to the innovative culture and commitment to creating excellent products that exists at Convergent Dental,” remarked Kerbage. “The folks at Convergent are true pioneers in dental laser technology, and their reputation for a superior customer experience is second to none. I am thrilled to be working with such a high-powered and motivated team of professionals.”

A technical leader with strong business acumen, Kerbage has over fifteen years of experience in scientific and technological innovation and has transitioned numerous technical developments into game-changing solutions in the medical devices, life sciences, and photonics industries.

Kerbage holds a PhD in Applied Physics from Columbia University, and an MBA from Boston University.

For more information about Solea, please visit www.convergentdental.com or call 844.GOSOLEA.

About Convergent Dental, Inc.

Convergent Dental, Inc. is a privately owned dental equipment and technology company. Solea® is the only computer-aided, CO2 laser system to be cleared by the FDA for all tissue indications. With Solea’s unique wavelength and computer controls, dentists can reliably perform procedures anesthesia-free, blood-free, suture-free, and pain-free. Reliably anesthesia-free and blood-free procedures pay huge dividends for patients in the form of a vastly improved dental experience and dentists in terms of significant practice growth. For more information, please visit www.convergentdental.com. Follow the company on Twitter, Facebook and LinkedIn.

Pulpdent Corporation, a dental research and manufacturing company, has joined forces with the UCLA School of Dentistry to prevent early childhood caries (i.e., tooth decay in infants and young children). Pulpdent is donating 600 applications of Embrace Fluoride Varnish and 2,500 applications of Embrace Pit & Fissure Sealant to the UCLA Infant Oral Care Program (IOCP) in 2018.

Learn more about Embrace Prevention from Pulpdent. 

According to research from UCLA and the Harvard School of Dental Medicine, "early childhood caries prevalence has increased significantly in children ages 2-5 years" and "disproportionally affects lower socioeconomic and minority groups." Programs like the UCLA IOCP offer free education, prevention, diagnosis and treatment for underserved infants and children at UCLA's local Federally Qualified Health Centers. The program also trains UCLA pediatric dental residents, dental students, pediatric medical residents, and advanced nurse practitioner students in culturally sensitive preventative oral health care.

During his trainings, Dr. Francisco Ramos-Gomez, UCLA IOCP founder, talks about the components in different dental products and how they impact patient outcomes. He says that in many cases, "people think that all fluoride varnish treatments are the same but they're not." Dr. Ramos-Gomez and his team use Embrace Varnish from Pulpdent to treat children at the UCLA IOCP because Embrace releases fluoride, calcium and phosphate (the basic building blocks of teeth). Many other commercially available fluoride varnish treatments release fluoride but not calcium and phosphate.

Pulpdent will also provide Embrace Pit and Fissure Sealant to the UCLA IOCP program. Embrace is the first sealant that bonds to the moist tooth and contains no BPA, Bis-GMA or BPA derivatives. Research shows remarkable sealing ability and adaptation to tooth structure.

About PULPDENT® Corporation

Pulpdent Corporation is a family-owned dental research, manufacturing company and leader in bioactive dental materials, with headquarters in Watertown, MA. For over 70 years Pulpdent has been committed to product innovation, clinical education and patient-centered care. ACTIVA BioACTIVE™, developed by Pulpdent, is a bioactive restorative material that behaves much like natural teeth, supports the natural remineralization process, and helps seal out decay. This revolutionary material has won The Dental Advisor Top Bioactive Product Award for three years running.